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The emergence of acquired carbapenemases is currently one ofthe most serious public health threats worldwide. These en-
zymes confer resistance to almost all-lactams, including carbap-
enems leading to very few therapeutic options for treating patients
infected by multidrug-resistant bacteria.
Here we report the identification of four environmental car-
bapenem-resistant Escherichia coli strains, E61, E201, E202, and
E203. These strainswere recovered in February 2015, from theAve
river, in the north of Portugal. Water samples of 100 ml were
filtered through 0.45-m-pore-size membrane filters (Millipore
Corporation, USA), which were then placed on tryptone bile X-
glucuronide agar (TBX) (BioKar Diagnostics, Beauvais, France)
plates supplemented with imipenem (2mg/liter). Strains growing
on those selective plates were checked for carbapenemase activity
by using theCarbaNP test (1). Antimicrobial susceptibility testing
was performed according to the standard disk diffusion method
following CLSI recommendations (2) and using cation-adjusted
Muller-Hinton plates (Bio-Rad, Cressier, Switzerland). The four
isolates were resistant to all -lactams, fluoroquinolones, and
aminoglycosides (except amikacin), being susceptible only to tige-
cycline and colistin. Two out of the four isolates (E61 and E202)
also remained susceptible to fosfomycin. MICs of carbapenems
(imipenem, ertapenem, and meropenem) were performed using
Etest strips (bioMérieux, La Balme-les-Grottes, France) (Table 1).
Molecular investigations were then performed by PCR using spe-
cific primers for carbapenemase genes (3) followed by sequencing
(Microsynth, Balgach, Switzerland). The phylogenetic group was
determined as previously described (4) and showed that isolates
E201 and E203 belonged to group E, strain E61 belonged to group
A, and strain E202 belonged to group F. Multilocus sequence typ-
ing performed as described previously (5) confirmed that isolates
E201 and E203 belonged to the same sequence type, whereas the
two other strains were clonally unrelated. PCR and sequencing
analysis revealed that strains E201 and E203 harbored the blaIMP-8
gene and strains E61 and E202 harbored the blaVIM-1 and blaVIM-34
genes, respectively.
Conjugation assays were performed in liquid medium using
the azide-resistant E. coli J53 as the recipient strain. Transconju-
gants were selected onto Luria-Bertani agar plates supplemented
with ertapenem (2mg/liter) and azide (100 mg/liter) to detect the
transfer of the carbapenemase genes. Transconjugants were ob-
tained for three out of the four isolates, but not for strain E202
despite repeated attempts. Plasmid extractions were performed
using the Kieser extraction method (6) using the environmental
strains and transconjugants. Further analysis showed that the
blaVIM-1 and blaIMP-8 genes were carried on a ca. 150-kb plasmid.
Molecular typing of plasmidswas performed using the PCR-based
replicon typing (Diatheva, Fano, Italy) (7), revealing that all plas-
mids bearing the carbapenemase genes belonged to the IncFIB
group.
The failure to obtain a transconjugant or transformant from
strain E202 suggests a possible chromosomal location of the
blaVIM-34 gene. It is noteworthy that the blaVIM-34 gene was
previously identified from Klebsiella pneumoniae in Portugal in
2013 and was found to be located on the chromosome (8). PCR
mapping followed by sequencing revealed that the blaVIM-34 gene
was embedded in class 1 integron In817 in strain E202, the exact
same structure as identified in the K. pneumoniae isolate from
Portugal (8).
The occurrence of carbapenemase-producing E. coli strains in
the aquatic environment remains worrying. Interestingly, we first
identified a KPC-producing E. coli in Portugal from the same
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TABLE 1MICs of carbapenems for the environmental isolates and E. coli J53 harboring the carbapenemase genes
Carbapenem or parameter
MIC (g/ml)a
Environmental isolates E. coli J53 transconjugants
E. coli J53E61 E201 E202 E203 E61TC E201TC E203TC
Imipenem 32 16 6 32 1 1.5 6 0.125
Meropenem 32 8 4 16 0.38 1 2 0.016
Ertapenem 32 16 4 32 0.38 0.5 3 0.012
Sequence type 167 2612 354 2612
a MICs of carbapenems are shown unless specified otherwise.
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river, as early as 2010 (9). This river may be a source of carbapen-
emase-producing E. coli or, conversely, humans might be the
source of this environmental contamination. Note that IMP-8
producers have been reported in Portugal (10) in K. pneumoniae
and Pseudomonas aeruginosa clinical isolates (11), suggesting a
wide spread of this carbapenemase, which is not commonly iden-
tified in other European countries.
Finally,monitoring the occurrence of carbapenemase-produc-
ing members of the family Enterobacteriaceae in the environment
can be of interest, since it may contribute to better control of the
occurrence and spread of these bacteria. It is therefore mandatory
to screen for carbapenemase producers not only among the hos-
pitalized populations but also among healthy people and potential
environmental cradles in order to identify possible hidden reser-
voirs.
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